Severe coronavirus disease 2019 (COVID‐19) pneumonia patients treated successfully with a combination of lopinavir/ritonavir plus favipiravir: Case series

Key Clinical Message The combination therapy of Lopinavir/Ritonavir plus Favipiravir might be a treatment option for patients with COVID‐19. Serum ferritin levels and lymphocytopenia are promising markers for disease severity and disease progression that are commonly available in general clinical pr...

Full description

Bibliographic Details
Published in:Clinical Case Reports
Main Authors: Hayato Koba, Taro Yoneda, Tomoya Kaneda, Tsukasa Ueda, Hideharu Kimura, Kazuo Kasahara
Format: Article
Language:English
Published: Wiley 2020-12-01
Subjects:
COVID‐19
favipiravir
ferritin
Lopinavir
lymphocytopenia
ritonavir
Online Access:https://doi.org/10.1002/ccr3.3358

Internet

https://doi.org/10.1002/ccr3.3358

Similar Items